Related Experiment Videos
Background, outcome, and clinical implications of the Multicenter Automatic Defibrillator Implantation Trial (MADIT)
1Department of Medicine, University of Rochester School of Medicine and Dentistry, New York 14642, USA.
The American Journal of Cardiology
|September 18, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The long-QT syndrome Genetic considerations.
Trends in cardiovascular medicine·2011
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·2007
Mutation-specific pharmacology of the long QT syndrome.
Handbook of experimental pharmacology·2006
Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.
Journal of thrombosis and haemostasis : JTH·2004
Long QT syndrome in children.
Journal of electrocardiology·2002
Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction.
The American journal of cardiology·2001
Procedural Characteristics and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With and Without Prior CABG.
The American journal of cardiology·2026
Predictors of Perioperative Major Adverse Cardiovascular Events After Bariatric Surgery.
The American journal of cardiology·2026
Risk Factors Associated with Decompensated Heart Failure Following Successful Cardioversion of Atrial Fibrillation and Atrial Flutter: A Validation Cohort.
The American journal of cardiology·2026
Efficacy and Safety of Zalunfiban by Creatinine Clearance Among Patients with ST-Elevation Myocardial Infarction: Analysis from the CELEBRATE Trial.
The American journal of cardiology·2026
SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.
Journal of translational medicine·2026